Clinical Trials Directory

Trials / Completed

CompletedNCT03431116

Low Implanted Second Trimester Placenta and Placenta Previa

The Prediction of Risk Factors of Progression of Low Implanted Placenta at 18- 24 Weeks to Placenta Previa at Term

Status
Completed
Phase
Study type
Observational
Enrollment
52 (actual)
Sponsor
Assiut University · Academic / Other
Sex
Female
Age
20 Years – 45 Years
Healthy volunteers
Accepted

Summary

Placenta Previa is defined as a placenta implanted in the lower segment of the uterus, presenting ahead of the leading pole of the fetus (over or near the internal os). The prevalence of placenta previa has been estimated to be approximately 0.5% of all pregnancies, and this increase correlates to the elevated cesarean section rate . In Egypt, the prevalence of placenta previa is around 1.3% in Sohag Governorate and 1.5% in Aswan region according to. Although various studies have tried to address risk factors associated with Placenta Previa development, the etiology of placenta previa still remains obscure. Several risk actors have been identified as strong contributors to placenta previa development. It is also a significant contributor to severe postpartum hemorrhage.Risk factors include; history of previous cesarean section, advanced maternal age, history of previous abortions, high parity and substance abuse during pregnancy (cigarette smoking), placental size (multiple pregnancy), endometrial damage (previous dilatation and curettage), uterine scars and pathology (previous myomectomy or endometritis), placental pathology (marginal cord insertions and succenturiate lobes), previous placental Previa, and curiously.

Conditions

Interventions

TypeNameDescription
RADIATIONultrasoundto detect the placental site

Timeline

Start date
2016-10-01
Primary completion
2017-03-30
Completion
2017-04-30
First posted
2018-02-13
Last updated
2018-02-13

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03431116. Inclusion in this directory is not an endorsement.